Abstract:In this study, we use cationic imidazole as the targeting group and phenoxazine as the electron donor, attaching phenoxazine to porphyrin via two different linking methods to synthesize two different phenoxazine-porphyrin photosensitizers (PSs), P1 and P2 , intended for photodynamic therapy (PDT) applications. Additionally, we synthesized a molecule, P3 , that does not contain the cationic imidazole group, to serve as a control PS. We comprehensively evaluate the performance of P1 and P2 through steady-state and transient spectroscopy analysis, theoretical calculations, photooxidation experiments, and in vitro cell experiments. The results showed that P1 and P2 exhibit excellent water solubility, longer triplet state lifetimes ( P1 at 200 μs, P2 at 170 μs), outstanding photostability, higher photooxidation rates and quantum yields of singlet oxygen ( 1 O 2 ). Notably, in the photooxidation experiment, P1 's photooxidation rate is 1.1 times that of P2 , and 1.5 times that of tetraphenyl zinc porphyrin (ZnTPP) without phenothiazine. This may be due to the larger Gibbs free energy difference between the singlet and triplet excited states in P1 (Δ G S-T of P1 is 0.87 eV, compared to 0.83 eV for P2 ), which results in a greater driving force for intersystem crossing (ISC) in P1 than in P2 . The introduction of the cationic imidazole group in P1 and P2 significantly enhances water solubility and tumor cell uptake compared to P3 , particularly showing higher intracellular accumulation and 1 O 2 generation capabilities in HepG2 tumor cells. Flow cytometry test results further confirmed the significant photocytotoxicity of P1 and P2 , with a marked decrease in survival rates after light exposure, where the survival rate of P1 nanoparticles (NPs) dropped to 41.7%, P2 NPs to 35.1%, and P3 NPs to 75.0%. The findings of this study provide crucial theoretical support for the design of new PSs.

Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy.

Synthesis of a new chlorin photosensitizer for photodynamic therapy against colon cancer

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

Bioinspired Design of Seco‐chlorin Photosensitizers to Overcome Phototoxic Effects in Photodynamic Therapy

Progress in Porphyrins As a Photosensitizing Drug for Photodynamic Therapy

Synthesis and evaluation of novel meso -substitutedphenyl dithieno[3,2-b]thiophene-fused BODIPY derivatives as efficient photosensitizers for photodynamic therapy

Novel BODIPY-based Nano-Biomaterials with Enhanced D-A-D Structure for NIR-triggered Photodynamic and Photothermal Therapy

Meso-substituted Porphyrin Photosensitizers with Enhanced Near-Infrared Absorption: Synthesis, Characterization and Biological Evaluation for Photodynamic Therapy

Novel pyropheophorbide a dimers: Synthesis and photobiological evaluation as potent photosensitizers for photodynamic therapy

Metabolizable Photosensitizer with Aggregation-Induced Emission for Photodynamic Therapy

Anti-tumor evaluation of a novel methoxyphenyl substituted chlorin photosensitizer for photodynamic therapy

Zinc phthalocyanine-bridged periodic mesoporous organosilica nanoparticle as biodegradable photosensitizer for photodynamic therapy

Β‐ionic Conjugated Chlorin‐Type Photosensitizers Based on Porpholactone: Synthesis, Photophysical Properties, and Photodynamic Activity

Synthesis, and evaluation of photophysical properties of a potential DPP-derived photosensitizer for photodynamic therapy with D-A-D architecture

Synthesis and properties of novel type I photosensitizer polycyclic amide

Novel Modified BODIPY–C60 As Photosensitizer in Photodynamic Therapy

Phototherapeutic applications of benzophenone-containing NIR-emitting photosensitizers based on different receptor modulations

Discovery of a Monoiodo Aza-BODIPY Near-Infrared Photosensitizer: in Vitro and in Vivo Evaluation for Photodynamic Therapy

Recent Progress in Thermally Activated Delayed Fluorescence Photosensitizers for Photodynamic Therapy

Novel dual-mode antitumor chlorin-based derivatives as potent photosensitizers and histone deacetylase inhibitors for photodynamic therapy and chemotherapy

Synthesis and evaluation of novel mitochondria-targeted, water-soluble phenoxazine-porphyrins for efficient photodynamic therapy